Search Results
CMS Issues New Guidance Addressing Spread Pricing in Medicaid, Ensures Pharmacy Benefit Managers are not Up-Charging Taxpayers
Agency issues guidance for Medicaid Managed Care and CHIP health plans that clarifies how current regulations require “spread pricing” to be accounted in the calculation of Medical Loss Ratios (MLRs)
Press releaseCMS Takes Action to Lower Prescription Drug Costs by Modernizing Medicare
Today, the Centers for Medicare & Medicaid Services (CMS) proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. The proposal would ensure that Medicare Advantage and Part D plans have more tools to negotiate lower drug prices, and the agency is also considering a policy that would require pharmacy rebates to be passed on to seniors to lower their drug costs at the pharmacy counter.
Press releaseCMS Proposes to Require Manufacturers to Disclose Drug Prices in Television Ads
Proposed rule would further the Trump Administration’s commitment to lower prescription drug prices by requiring companies to list prices for prescription drugs covered in Medicare or Medicaid.
Press releaseIndication-Based Formulary Design Beginning in Contract Year (CY) 2020
Today, the Centers for Medicare & Medicaid Services (CMS) announced additional flexibilities in the Medicare Part D program to allow for innovative formulary design as a valuable approach to expand drug choices and address the challenge of high drug costs for seniors and government programs.
Fact sheetCMS provides new flexibility to increase prescription drug choices and strengthen negotiation for Medicare enrollees
The Centers for Medicare & Medicaid Services (CMS) issued a memo today to Medicare Part D plans, which cover prescription drugs that beneficiaries pick up at a pharmacy, offering plans new tools and flexibility to expand choices and lower drug prices for patients.
Press releaseCMS Sends Clear Message to Plans: Stop Hiding Information from Patients
Today, the Centers for Medicare & Medicaid Services sent a letter to companies that provide Medicare prescription drug coverage in Part D explaining that so-called “gag clauses” are unacceptable, as part of the Administration-wide “American Patients First” initiative to lower prescription drug costs.
Press releaseSpeech: Remarks by CMS Administrator Seema Verma at the Pharmacy Quality Alliance Annual Meeting
Good afternoon, it’s a pleasure to be with you today. Pharmacists are on the front lines of patient care and have keen insight to the issues that patients face. We appreciate your hard work, and we look forward to working with you on a goal that I’m sure we share – ensuring that all patients can access their medications at an affordable price.
Fact sheetCMS Strategy to Combat Medicare Part D Prescription Drug Fraud and Abuse
Prescription drug abuse is a serious and growing problem nationwide. Unfortunately, the Medicare Part D prescription drug program (Part D) is not immune from the abuses associated with this nationwide epidemic.
Fact sheetHHS PARTNERS WITH PHARMACIES TO EDUCATE MEDICARE BENEFICIARIES ABOUT NEW HEALTH BENEFITS
Today, Health and Human Services (HHS) Secretary Kathleen Sebelius announced partnerships with several pharmacies to help customers learn about new Medicare benefits available to them under the Affordable Care Act – the health care law.
Press release